AMPE News and Press, Ampio Pharmaceuticals Inc. From 07/02/20

Are These Penny Stocks On Your List To Buy Or Sell Before The Holiday? We’ve said it in the past, just because something’s low-priced, doesn’t mean it’s good to buy. However, when you talk about penny stocks , the word “cheap” can be a big plus. Now, ...

Regeneron Receives FDA Nod for Dupixent Regeneron Pharmaceuticals ( REGN ) reported that the FDA has given its approval for a 300 mg single-dose prefilled pen formulation of Dupixent. The drug is now authorized for treating certain patients at least 12 years old with atopic dermatitis, a...

Following FDA sign-off, Ampio Pharmaceuticals ( AMPE +24.9% ) has initiated a Phase 1 clinical trial evaluating intravenous Ampion therapy on hospitalized COVID-19 patients on supplemental oxygen. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the ...

ENGLEWOOD, Colo. , June 19, 2020 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") ,  is a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, th...

Ampio Pharmaceuticals (NYSEMKT: AMPE ) has filed IND applications with the FDA seeking sign-off to conduct clinical trials evaluating inhaled and intravenous formulations of Ampion , a low molecular weight fraction of human serum albumin, for the potential treatment of COVID-19. More ne...

ENGLEWOOD, Colo. , May 22, 2020 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) is a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the company is de...

ENGLEWOOD, Colo. , May 11, 2020 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the development of immunology based therapies for prevalent inflammatory conditions, today announced a manuscript accepted for publica...

The top pharmaceutical companies are trying every approach they can imagine to find the weakness in COVID-19’s armor. Pharma companies that were arch enemies are working together. Drugs that are approved for other diseases are being tested as treatments. The front runner is Gilead Scien...

Are These Penny Stocks To Buy Or Avoid Right Now? The topic came up recently on our Twitter feed so I thought I’d take time to address it. Seeing as so many people are looking at companies trading below $5, some may not be apprised of what penny stocks are. If you don’t know th...

ENGLEWOOD, Colo. , April 2, 2020 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a pre-revenue development stage biopharmaceutical company focused on the development of immunology based therapies to treat prevalent inflammatory conditions announced today tha...